Ethan Basch, MD, MSc

Richard M. Goldberg Distinguished Professor of Medical Oncology
Chief, Division of Oncology
Physician-in-Chief, NC Cancer Hospital
Professor, Health Policy and Management, UNC Gillings School of Global Public Health
Director, Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center
Co-leader, Cancer Prevention and Control Program, Lineberger

CC 2020 Top Doctor Logo

Specialty Areas

Medical Oncology, Prostate Cancer, and Outcomes Research

Chronology

  Degree   Institution   Area
  BA   Brown University   English
  MPhil   Oxford University   Literature
  MD   Harvard Medical School   Medicine
  MSc   Harvard School of Public Health   Epidemiology
  Internship/Residency   Massachusetts General Hospital   Internal Medicine
  Fellowship   Memorial Sloan Kettering Cancer Center   Oncology

 

Research and Clinical Interests

Dr. Basch is a medical oncologist specializing in the treatment of men with prostate cancer.  He has led and participated in many of the national guidelines on the treatment of prostate cancer.  He leads a research program focused on improving the patient-centeredness and quality of cancer care and oncology drug development.  He has developed tools with the National Cancer Institute that are widely used for collecting symptom information directly from patients.  His research demonstrated that electronic symptom monitoring during cancer treatment improves patients’ quality of life, reduces hospitalizations, and lengthens survival.  He serves on the Board of Directors of the American Society of Clinical Oncology (ASCO), on the Editorial Board of the Journal of the American Medical Association (JAMA), and previously completed terms on the Board of Scientific Advisors of the National Cancer Institute (NCI), the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), the Board of Directors of the International Society for Quality of Life Research (ISOQOL), and the NCI Steering Committee for Cancer Care Delivery Research.

Personal Statement

I believe deeply in the importance of listening to patients, communicating options clearly, and coming to shared decisions about treatment.  Quality of life is one of my highest goals for patients and families.  I try my best to understand the values and experiences of patients, and to provide support as well as needed information.  I appreciate that everyone makes unique decisions for their own situation and beliefs.  I work with an outstanding team of colleagues who help with each patient, including nurse “navigators” who help patients and families understand the complexities of receiving cancer care; pharmacists who review drugs and explain side effects; and counselors when needed.  At UNC, we have many clinical trials that may be an option for patients, depending on their situation, and it is my goal to offer patients the best and most up-to-date treatment options.

Awards and Honors

  • 2019: Association of Community Cancer Centers (ACCC) Clinical Research Award
  • 2019: Elected to Board of Directors, American Society of Clinical Oncology (ASCO)
  • 2018: Elected to the American Society for Clinical Investigation (ASCI)
  • 2017: Ware/Tarlov Career Achievement Prize
  • 2017: Visiting Scholar, University of Birmingham, England
  • 2016: Visiting Scholar, Dartmouth University
  • 2012: Appointee, Board of Scientific Advisors, National Cancer Institute
  • 2012: Visiting Professor, Johns Hopkins School of Medicine
  • 2011: Board of Directors, International Society for Quality of Life Research
  • 2011: Federal Appointee, Patient-Centered Outcomes Research Institute (PCORI), Methodology Committee
  • 2006: Career Development Award, American Society of Clinical Oncology
  • 2004: Research Investigator Award, Cancer and Leukemia Group B
  • 2004: Carbone Young Investigator Award, Geriatric Oncology Consortium
  • 2004 – 2006: Merit Awards, American Society of Clinical Oncology
  • 1997: Collins Research Award, Harvard Medical School
  • 1996: Lally Research Scholarship, Harvard University
  • 1996: Albert Schweitz Fellowship
  • 1989: Fulbright Scholarship
  • 1989: Baker Research Fellowship, Brown University
  • 1989: Phi Beta Kappa, Magna cum laude

Find publications on PubMed